Epithelial-mesenchymal transition triggers cancer stem cell

International Journal of Oncology

Volumn 43, Issue 1, 2013, Pages 113-120

  Lan, Ling ^a   Luo, Yong ^b   Cui, Dai ^c   Shi, Bing Yin ^d   Deng, Wei ^a   Huo, Li Li ^a   Chen, Hai Ling ^a   Zhang, Guo Ying ^a   Deng, Li Li ^a  

^a Jishuitan Orthopaedic College of Tsinghua University   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cancer stem cell; Epithelial mesenchymal transition; Hypoxic inducible factor 1 ; Thyroid

Indexed keywords

BETA ACTIN; BREAST CANCER RESISTANCE PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OCTAMER TRANSCRIPTION FACTOR 4; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER GROWTH; CANCER PREVENTION; CANCER STAGING; CANCER STEM CELL; CELL ASSAY; CELL CULTURE; CELL INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; THYROID CANCER; WESTERN BLOTTING;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CADHERINS; CARCINOGENESIS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; THYROID NEOPLASMS;

EID: 84879647438     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1913     Document Type: Article

References (39)

1. Are C and Shaha AR: Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors and treatment approaches. Ann Surg Oncol 13: 453-464, 2006.
2. Jordan CT, Guzman ML and Noble M: Cancer stem cells. N Engl J Med 355: 1253-1261, 2006. (Pubitemid 44427449)
3. Ward RJ and Dirks PB: Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol 2: 175-189, 2007. (Pubitemid 46448063)
4. Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101: 781-786, 2004. (Pubitemid 38121035)
5. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233, 2004. (Pubitemid 39305058)
6. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Re 63: 5821-5828, 2003. (Pubitemid 37187480)
7. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183, 2003. (Pubitemid 37518036)
8. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD and Steindler DA: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39: 193-206, 2002.
9. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997. (Pubitemid 27298715)
10. + anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One 4: e5395, 2009.
11. Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M, Pizzolanti G, Galluzzo A and Giordano C: In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS One 3: e3544, 2008.
12. Thomas D, Friedman S and Lin RY: Thyroid stem cells: lessons from normal development and thyroid cancer. Endocr Relat Cancer 15: 51-58, 2008. (Pubitemid 351449727)
13. Thomas T, Nowka K, Lan L and Derwahl M: Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid 16: 537-544, 2006. (Pubitemid 44066260)
14. Lan L, Cui D, Nowka K and Derwahl M: Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes. J Clin Endocrinol Metab 92: 3681-3688, 2007. (Pubitemid 47435356)
15. Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S and Gallinella-Muzi M: Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol 198: 471-487, 2008.
16. Zheng XQ, Cui D, Xu SH, Brabant G and Dereahl M: Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol 37: 307-315, 2010.
17. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V and Yamashita S: Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148: 1797-1803, 2007. (Pubitemid 46457095)
18. Takano T and Amino N: Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid 15: 432-438, 2005. (Pubitemid 40770622)
19. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
20. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA: The epithelial mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008. (Pubitemid 351636299)
21. Raimondi C, Gianni W, Cortesi E and Gazzaniga P: Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. Current Cancer Drug Targets 10: 496-508, 2010.
22. Hollier BG, Evans K and Mani SA: The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia 14: 29-43, 2009.
23. Hayashida T, Jinno H, Kitagawa Y and Kitajima M: Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis. J Oncol 2011: 591427, 2011.
24. Goretzki PE, Frilling A, Simon D and Roeher HD: Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res 118: 48-63, 1990.
25. Luo Y, He DL, Ning L, Shen SL, Li L, Li X, Zhau HE and Chung LW: Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro. BJU Int 98: 1315-1319, 2006. (Pubitemid 44721249)
26. Hundahl SA, Fleming ID, Fremgen AM and Menck HR: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83: 2638-2648, 1998. (Pubitemid 29019586)
27. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S and Sarkar FH: Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5: e12445, 2010.
28. Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB and Farrar WL: Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis 26: 433-446, 2009.
29. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005. (Pubitemid 41267170)
30. Salnikov AV, Liu L, Platen M, Gladkich J, Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J, Schemmer P, Buechler MW and Herr I: Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One 7: e46391, 2012.
31. Lu X and Kang YB: Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 16: 5928-5935, 2010.
32. Mimeault M and Batra SK: Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J Cell Mol Med 17: 30-54, 2013.
33. Nelson WJ and Nusse R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487, 2004. (Pubitemid 38314410)
34. Kim K, Lu Z and Hay ED: Direct evidence for a role of beta-catenin/ LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26: 463-476, 2002. (Pubitemid 34762099)
35. Medici D, Hay ED and Olsen BR: Snail and Slug promote epithelialmesenchymal transition through beta-catenin-T-cell factor-4- dependent expression of transforming growth factor-beta3. Mol Biol Cell 19: 4875-4887, 2008.
36. Yang L, Lin C and Liu ZR: P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell 127: 139-155, 2006. (Pubitemid 44466634)
37. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006.
38. Hurt EM, Chan K, Serrat MA, Thomas SB, Veenstra TD and Farrar WL: Identification of vitronectin as an extrinsic inducer of cancer stem celldifferentiation and tumor formation. Stem Cell 28: 390-398, 2010.
39. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S and Puisieux A: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888, 2008.